| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NM0397-293 |
| P698 | PubMed publication ID | 9055856 |
| P50 | author | Yuan Chang | Q438541 |
| P2093 | author name string | T Sato | |
| J J Russo | |||
| R A Bohenzky | |||
| R Sarid | |||
| P2860 | cites work | Herpesvirus-like DNA Sequences in Non-AIDS Kaposi's Sarcoma | Q71829854 |
| Viruses and apoptosis | Q72234473 | ||
| Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death | Q24311298 | ||
| Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death | Q24312211 | ||
| Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 | ||
| Basic local alignment search tool | Q25938991 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma | Q28284765 | ||
| Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells | Q28294137 | ||
| Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection | Q28299060 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 | Q28645710 | ||
| Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death | Q29620000 | ||
| A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. | Q33459927 | ||
| Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells | Q33862904 | ||
| Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma | Q34383343 | ||
| The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission | Q34388952 | ||
| Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. | Q34408877 | ||
| Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation | Q34559025 | ||
| Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma | Q34735185 | ||
| Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma | Q35617276 | ||
| Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. | Q35774469 | ||
| Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death | Q36535182 | ||
| Stable growth transformation of human T lymphocytes by herpesvirus saimiri | Q36939191 | ||
| Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group | Q38888545 | ||
| A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma | Q39435212 | ||
| Regulation of Apoptosis by the Transforming Genes of the DNA Tumor Virus Adenovirus | Q40489935 | ||
| An evolutionary perspective on apoptosis. | Q40723583 | ||
| EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. | Q40792597 | ||
| Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma | Q40972068 | ||
| Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. | Q41198290 | ||
| A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis | Q41206213 | ||
| Cyclin encoded by KS herpesvirus | Q42633290 | ||
| Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins | Q43566357 | ||
| Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. | Q43932714 | ||
| Pattern-induced multi-sequence alignment (PUMA) algorithm employing secondary structure-dependent gap penalties for use in comparative protein modelling | Q44253383 | ||
| Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis | Q45859903 | ||
| Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. | Q46607939 | ||
| Cloning and sequencing of a cDNA encoding the rat Bcl-2 protein | Q48084047 | ||
| Random cloning and sequencing by the M13/dideoxynucleotide chain termination method. | Q54769070 | ||
| Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene | Q67563319 | ||
| Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma | Q71800881 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 293-298 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue | |
| P478 | volume | 3 |
| Q41098043 | A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit |
| Q33815534 | A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. |
| Q33816818 | A portrait of the Bcl-2 protein family: life, death, and the whole picture |
| Q53193404 | A role for Epstein-Barr viral BALF1 in facilitating tumor formation and metastasis potential. |
| Q34754656 | A view to a kill: ligands for Bcl-2 family proteins |
| Q36893107 | AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa? |
| Q59621919 | AIDS-associated malignancies |
| Q78169772 | AIDS-associated malignancies: research perspectives |
| Q35973882 | AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. "On the offensive--the Trojan Horse is being destroyed"--Part A: Kaposi's sarcoma |
| Q37252864 | Activation of human herpesvirus replication by apoptosis |
| Q41682881 | Aetiology of Kaposi's sarcoma: current understanding and implications for therapy |
| Q34703643 | Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways |
| Q77454770 | Anti-apoptotic strategies of lymphotropic viruses |
| Q33547796 | Anti-viral strategies of cytotoxic T lymphocytes are manifested through a variety of granule-bound pathways of apoptosis induction |
| Q39582480 | Antiapoptotic activity of the herpesvirus saimiri-encoded Bcl-2 homolog: stabilization of mitochondria and inhibition of caspase-3-like activity. |
| Q33787044 | Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins |
| Q35569183 | Antigen- and/or immune-driven lymphoproliferative disorders |
| Q36239688 | Apoptosis in normal and diseased oral tissues |
| Q53854543 | Apoptosis regulators from DNA viruses. |
| Q35747595 | Apoptosis-induced activation of HIV-1 in latently infected cell lines |
| Q38404747 | Association of multiple myeloma--Kaposi's sarcoma: report of a case |
| Q39767301 | Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines |
| Q35641404 | BH3 Profiling Reveals Selectivity by Herpesviruses for Specific Bcl-2 Proteins To Mediate Survival of Latently Infected Cells. |
| Q28590981 | BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2 |
| Q53947366 | Bcl-2 family proteins and mitochondria. |
| Q37641750 | CD40 upregulation is independent of HHV-8 in the pathogenesis of Kaposi's sarcoma |
| Q39365643 | Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus |
| Q37895629 | Cell death-independent functions of granzymes: hit viruses where it hurts |
| Q37945182 | Cellular players in the herpes simplex virus dependent apoptosis balancing act. |
| Q40890887 | Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12). |
| Q38795372 | Coexistence of intestinal Kaposi sarcoma and plasmablastic lymphoma in an HIV/AIDS patient: case report and review of the literature |
| Q34061960 | Comparative analysis of the transforming mechanisms of Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and Herpesvirus saimiri |
| Q37228185 | Cyclin D1 expression and HHV8 in Kaposi sarcoma |
| Q28217065 | Death and anti-death: tumour resistance to apoptosis |
| Q35031970 | Death and survival: viral regulation of TNF signaling pathways |
| Q43928275 | Detection of serum antibodies to three different recombinant antigens of human herpesvirus 8 by immunoblotting: seroprevalence studies in Taiwan |
| Q24803532 | Development of real-time NASBA assays with molecular beacon detection to quantify mRNA coding for HHV-8 lytic and latent genes |
| Q34331772 | Differential expression of viral Bcl-2 encoded by Kaposi's sarcoma-associated herpesvirus and human Bcl-2 in primary effusion lymphoma cells and Kaposi's sarcoma lesions |
| Q27020978 | Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer |
| Q37682897 | Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir |
| Q33786189 | Distinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas |
| Q39585165 | Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins |
| Q78860218 | Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes |
| Q39748049 | Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins |
| Q39594322 | Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. |
| Q41655689 | Errors of homeostasis and deregulated apoptosis |
| Q42612163 | Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. |
| Q24305049 | Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein |
| Q39582084 | Functional differences between BHRF1, the Epstein-Barr virus-encoded Bcl-2 homologue, and Bcl-2 in human epithelial cells |
| Q30090237 | GLTSCR2/PICT-1, a putative tumor suppressor gene product, induces the nucleolar targeting of the Kaposi's sarcoma-associated herpesvirus KS-Bcl-2 protein |
| Q36445916 | Gene alteration and precursor and mature microRNA transcription changes contribute to the miRNA signature of primary effusion lymphoma. |
| Q77495214 | Genome-wide search for loss of heterozygosity in Burkitt lymphoma cell lines |
| Q34782463 | Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator |
| Q34055787 | Herpesvirus homologues of cellular genes |
| Q47552231 | Human Herpesvirus 8 Interferon Regulatory Factors 1 and 3 Mediate Replication and Latency Activities via Interactions with USP7 Deubiquitinase |
| Q35086996 | Human Herpesvirus 8: Biology and Role in the Pathogenesis of Kaposi's Sarcoma and Other AIDS-related Malignancies |
| Q37641105 | Human herpes virus 8 (HHV-8) in Kaposi's sarcoma: lack of association with Bcl-2 and p53 protein expression |
| Q34299388 | Human herpesvirus 8 interferon regulatory factor-mediated BH3-only protein inhibition via Bid BH3-B mimicry |
| Q81037620 | Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignancies |
| Q34295801 | Human herpesvirus-8 and Kaposi's sarcoma: relationship with the multistep concept of tumorigenesis. |
| Q40704555 | Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line |
| Q34614394 | Human tumor-associated viruses and new insights into the molecular mechanisms of cancer |
| Q30840864 | Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus |
| Q35720026 | Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses |
| Q39575857 | Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus |
| Q33784194 | Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene |
| Q35641400 | Identification of the Essential Role of Viral Bcl-2 for Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication. |
| Q36370194 | Identification of the in vivo role of a viral bcl-2 |
| Q34795543 | Immune Evasion by Kaposi‘s Sarcoma-Associated Herpesvirus |
| Q37307209 | Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis |
| Q45077858 | Immune evasion strategies of the human gamma-herpesviruses: implications for viral tumorigenesis |
| Q44477708 | Immunohistochemical detection of Bcl-2 in Kaposi's sarcoma lesions varies according to histopathologic stage, whereas expression of Bcl-x and Mcl-1 differs according to human immunodeficiency virus serologic status of patients |
| Q40101366 | In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle |
| Q39789584 | In vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors |
| Q27676390 | Inhibition of Apoptosis and NF-κB Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence |
| Q33966269 | Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor |
| Q28080898 | Interference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma Herpesviruses |
| Q28757509 | Intracellular Kaposi's sarcoma-associated herpesvirus load determines early loss of immune synapse components |
| Q35784760 | Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. |
| Q37488130 | KSHV 2.0: a comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features |
| Q40375800 | KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. |
| Q40509197 | KSHV reduces autophagy in THP-1 cells and in differentiating monocytes by decreasing CAST/calpastatin and ATG5 expression |
| Q34644229 | Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation. |
| Q29394711 | Kaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin? |
| Q74292311 | Kaposi's sarcoma |
| Q36487309 | Kaposi's sarcoma and its associated herpesvirus |
| Q34343562 | Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replication |
| Q33834993 | Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53 |
| Q33960391 | Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma. |
| Q38305362 | Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays |
| Q24538918 | Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis |
| Q33784902 | Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor |
| Q36438139 | Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor confers resistance to the antiproliferative effect of interferon-alpha |
| Q53947567 | Kaposi's sarcoma-associated herpesvirus. |
| Q33671160 | Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology |
| Q61641140 | Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents |
| Q34191778 | Kaposi's sarcoma: aetiopathogenesis, histology and clinical features |
| Q45436282 | LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3. |
| Q73412387 | Levels of the bcl-2 protein, fibronectin and alpha(5)beta(1) fibronectin receptor in HIV-1-infected patients with Kaposi's sarcoma |
| Q37568044 | Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation |
| Q28140555 | Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style |
| Q36226733 | Mitochondria as functional targets of proteins coded by human tumor viruses |
| Q50320474 | Mitochondrial Proteins Coded by Human Tumor Viruses |
| Q35801076 | Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies |
| Q37512255 | Modulation of autophagy-like processes by tumor viruses |
| Q35124404 | Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis |
| Q37210546 | Molecular analysis of clonality in Kaposi's sarcoma. |
| Q27652185 | Molecular basis of the regulation of Beclin 1-dependent autophagy by the gamma-herpesvirus 68 Bcl-2 homolog M11 |
| Q33560572 | Molecular biology of KSHV in relation to AIDS-associated oncogenesis |
| Q35026060 | Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis |
| Q34234132 | Molecular piracy of Kaposi's sarcoma associated herpesvirus |
| Q28363323 | Molecular virology of Kaposi's sarcoma-associated herpesvirus |
| Q77148150 | Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis |
| Q27469488 | Natural history of murine -herpesvirus infection |
| Q39165259 | No evidence for a role of human herpesvirus type 8 in sarcoidosis: molecular and serological analysis |
| Q34564288 | Noninfectious pulmonary complications of human immunodeficiency virus infection |
| Q39105335 | Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virions |
| Q59353447 | Operation of mitochondrial machinery in viral infection-induced immune responses |
| Q33724002 | Perspective on Kaposi's sarcoma: facts, concepts, and conjectures |
| Q37868566 | Pharmacological management of Kaposi's sarcoma |
| Q36850385 | Phosphorylation drives an apoptotic protein to activate antiapoptotic genes: paradigm of influenza A matrix 1 protein function |
| Q52571131 | Possible Association of Multicentric Castleman's Disease with Autoimmune Lymphoproliferative Syndrome. |
| Q41003721 | Purification of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) and analyses of the structural proteins |
| Q40546002 | RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA |
| Q38246971 | Regulation of the metastasis suppressor Nm23-H1 by tumor viruses |
| Q35802945 | Selective peptide inhibitors of antiapoptotic cellular and viral Bcl-2 proteins lead to cytochrome c release during latent Kaposi's sarcoma-associated herpesvirus infection. |
| Q40686461 | Seroprevalence of Kaposi's sarcoma-associated herpesvirus infection among blood donors from Texas. |
| Q36363353 | Sheeppox virus SPPV14 encodes a Bcl-2-like cell death inhibitor that counters a distinct set of mammalian proapoptotic proteins. |
| Q27638414 | Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus |
| Q35125136 | Split genes and their expression in Kaposi's sarcoma‐associated herpesvirus |
| Q34359241 | Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction |
| Q30311122 | Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus |
| Q26866936 | Targeting the Bcl-2 family for cancer therapy |
| Q27681394 | Targeting -Herpesvirus 68 Bcl-2-mediated Down-regulation of Autophagy |
| Q41922877 | The Bcl-2 Family in Host-Virus Interactions. |
| Q92662243 | The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms |
| Q36400220 | The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS |
| Q40599174 | The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells |
| Q38722941 | The Viral Bcl-2 Homologs of Kaposi's Sarcoma-Associated Herpesvirus and Rhesus Rhadinovirus Share an Essential Role for Viral Replication. |
| Q54031813 | The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. |
| Q39879780 | The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. |
| Q34330221 | The domains of apoptosis: a genomics perspective |
| Q35083049 | The essential role of evasion from cell death in cancer |
| Q41732751 | The fight of viruses against apoptosis |
| Q39860135 | The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. |
| Q38305743 | The matrix (M) protein of Newcastle disease virus binds to human bax through its BH3 domain. |
| Q34605505 | The molecular pathology of Kaposi's sarcoma-associated herpesvirus |
| Q41659044 | The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy |
| Q35847738 | The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production |
| Q33653581 | Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice |
| Q34983824 | To kill or be killed: viral evasion of apoptosis |
| Q34069105 | Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1) |
| Q36524071 | Transcription program of murine gammaherpesvirus 68 |
| Q39612361 | Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene |
| Q39984550 | Tumor cells expressing a fusion protein of MULT1 and Fas are rejected in vivo by apoptosis and NK cell activation |
| Q37348840 | Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. |
| Q34764819 | Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma |
| Q38256387 | Utilising proteomic approaches to understand oncogenic human herpesviruses (Review). |
| Q39707773 | Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention |
| Q35641410 | Viral Bcl-2 Encoded by the Kaposi's Sarcoma-Associated Herpesvirus Is Vital for Virus Reactivation |
| Q33920746 | Viral cyclins |
| Q39318008 | Viral hijacking of host caspases: an emerging category of pathogen-host interactions. |
| Q36246428 | Viral infection: an evolving insight into the signal transduction pathways responsible for the innate immune response |
| Q35619821 | Viral product trafficking to mitochondria, mechanisms and roles in pathogenesis |
| Q34234104 | Viral proteins and the mitochondrial apoptotic checkpoint |
| Q35091480 | Viral versus cellular BCL-2 proteins |
| Q34469316 | Virus infections: escape, resistance, and counterattack. |
| Q34308884 | Viruses and apoptosis |
| Q35145651 | Viruses and the TNF-related cytokines, an evolving battle |
| Q37791919 | When autophagy meets viruses: a double-edged sword with functions in defense and offense |
| Q34648862 | vMIA, a viral inhibitor of apoptosis targeting mitochondria |
Search more.